519242 (1)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists 72,50,000 new equity shares of Sarda Proteins Ltd issued on preferential basis via warrant conversion, effective May 12, 2026. … | |||||||||||||||
BSE lists 72,50,000 new equity shares of Sarda Proteins Ltd issued on preferential basis via warrant conversion, effective May 12, 2026. Majority shares are subject to lock-in until November 2027.
| |||||||||||||||